Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Increasing Ebola transmission behaviors 6 months post-vaccination: Comparing vaccinated and unvaccinated populations near 2018 Mbandaka Ebola outbreak in the Democratic Republic of Congo.
Hoff NA, Bratcher A, Mukadi P, Ahuka S, Kabamba M, Musene K, Halbrook M, Dzogong C, Mwamba GN, Mbala P, Kelly JD, Kompany JP, Tambu M, Kaba D, Kebela-Ilunga B, Muyemebe-Tamfum JJ, Rimoin AW. Hoff NA, et al. Among authors: mbala p. Vaccine. 2021 Dec 17;39(51):7464-7469. doi: 10.1016/j.vaccine.2021.10.071. Epub 2021 Nov 16. Vaccine. 2021. PMID: 34799143 Free PMC article.
Ebola virus disease in the Democratic Republic of the Congo, 1976-2014.
Rosello A, Mossoko M, Flasche S, Van Hoek AJ, Mbala P, Camacho A, Funk S, Kucharski A, Ilunga BK, Edmunds WJ, Piot P, Baguelin M, Tamfum JJ. Rosello A, et al. Among authors: mbala p. Elife. 2015 Nov 3;4:e09015. doi: 10.7554/eLife.09015. Elife. 2015. PMID: 26525597 Free PMC article.
Evaluating the frequency of asymptomatic Ebola virus infection.
Mbala P, Baguelin M, Ngay I, Rosello A, Mulembakani P, Demiris N, Edmunds WJ, Muyembe JJ. Mbala P, et al. Philos Trans R Soc Lond B Biol Sci. 2017 May 26;372(1721):20160303. doi: 10.1098/rstb.2016.0303. Philos Trans R Soc Lond B Biol Sci. 2017. PMID: 28396474 Free PMC article.
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.
Mulangu S, Dodd LE, Davey RT Jr, Tshiani Mbaya O, Proschan M, Mukadi D, Lusakibanza Manzo M, Nzolo D, Tshomba Oloma A, Ibanda A, Ali R, Coulibaly S, Levine AC, Grais R, Diaz J, Lane HC, Muyembe-Tamfum JJ; PALM Writing Group; Sivahera B, Camara M, Kojan R, Walker R, Dighero-Kemp B, Cao H, Mukumbayi P, Mbala-Kingebeni P, Ahuka S, Albert S, Bonnett T, Crozier I, Duvenhage M, Proffitt C, Teitelbaum M, Moench T, Aboulhab J, Barrett K, Cahill K, Cone K, Eckes R, Hensley L, Herpin B, Higgs E, Ledgerwood J, Pierson J, Smolskis M, Sow Y, Tierney J, Sivapalasingam S, Holman W, Gettinger N, Vallée D, Nordwall J; PALM Consortium Study Team. Mulangu S, et al. Among authors: mbala kingebeni p. N Engl J Med. 2019 Dec 12;381(24):2293-2303. doi: 10.1056/NEJMoa1910993. Epub 2019 Nov 27. N Engl J Med. 2019. PMID: 31774950 Free PMC article. Clinical Trial.
Ebola Virus Disease Outbreak - Democratic Republic of the Congo, August 2018-November 2019.
Aruna A, Mbala P, Minikulu L, Mukadi D, Bulemfu D, Edidi F, Bulabula J, Tshapenda G, Nsio J, Kitenge R, Mbuyi G, Mwanzembe C, Kombe J, Lubula L, Shako JC, Mossoko M, Mulangu F, Mutombo A, Sana E, Tutu Y, Kabange L, Makengo J, Tshibinkufua F, Ahuka-Mundeke S, Muyembe JJ, Cdc ER; CDC Ebola Response. Aruna A, et al. Among authors: mbala p. MMWR Morb Mortal Wkly Rep. 2019 Dec 20;68(50):1162-1165. doi: 10.15585/mmwr.mm6850a3. MMWR Morb Mortal Wkly Rep. 2019. PMID: 31856146 Free PMC article.
High Prevalence of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (Anti-SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey.
Nkuba AN, Makiala SM, Guichet E, Tshiminyi PM, Bazitama YM, Yambayamba MK, Kazenza BM, Kabeya TM, Matungulu EB, Baketana LK, Mitongo NM, Thaurignac G, Leendertz FH, Vanlerberghe V, Pelloquin R, Etard JF, Maman D, Mbala PK, Ayouba A, Peeters M, Muyembe JT, Delaporte E, Ahuka SM. Nkuba AN, et al. Clin Infect Dis. 2022 Mar 9;74(5):882-890. doi: 10.1093/cid/ciab515. Clin Infect Dis. 2022. PMID: 34089598 Free PMC article.
Post-exposure prophylaxis following high-risk contact with Ebola virus, using immunotherapies with monoclonal antibodies, in the eastern Democratic Republic of the Congo: an emergency use program.
Jaspard M, Juchet S, Serra B, Mayoum B, Kanta IM, Camara MS, Mbala P, Kojan R, Malvy D. Jaspard M, et al. Among authors: mbala p. Int J Infect Dis. 2021 Dec;113:166-167. doi: 10.1016/j.ijid.2021.09.053. Epub 2021 Sep 26. Int J Infect Dis. 2021. PMID: 34587535 Free article.
36 results